Literature DB >> 11122230

X-linked lymphoproliferative syndrome.

D L Nelson1, C Terhorst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11122230      PMCID： PMC1905809          DOI： 10.1046/j.1365-2249.2000.01400.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Diagnostic guidelines--An International Consensus document.

Authors:  M E Conley
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

3.  Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children.

Authors:  A J Provisor; J J Iacuone; R R Chilcote; R G Neiburger; F G Crussi
Journal:  N Engl J Med       Date:  1975-07-10       Impact factor: 91.245

Review 4.  The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990.

Authors:  D T Purtilo; H L Grierson; J R Davis; M Okano
Journal:  Pediatr Pathol       Date:  1991 Sep-Oct

5.  Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition.

Authors:  F Poy; M B Yaffe; J Sayos; K Saxena; M Morra; J Sumegi; L C Cantley; C Terhorst; M J Eck
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

6.  Fatal infectious mononucleosis in a family.

Authors:  R S Bar; C J DeLor; K P Clausen; P Hurtubise; W Henle; J F Hewetson
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

7.  Letter: Fatal infectious mononucleosis in familial lymphohistiocytosis.

Authors:  D T Purtilo; C Cassel; J P Yang
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

8.  Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis.

Authors:  M E Kadin; M Kamoun; J Lamberg
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

9.  Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.

Authors:  C Wu; J Sayos; N Wang; D Howie; A Coyle; C Terhorst
Journal:  Immunogenetics       Date:  2000-08       Impact factor: 2.846

10.  Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.

Authors:  K C Gilmour; T Cranston; A Jones; E G Davies; D Goldblatt; A Thrasher; C Kinnon; K E Nichols; H B Gaspar
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532
View more
  3 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai.

Authors:  Xiaoshu Cai; Georgi Z Genchev; Ping He; Hui Lu; Guangjun Yu
Journal:  Orphanet J Rare Dis       Date:  2021-06-08       Impact factor: 4.123

Review 3.  Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.

Authors:  Masafumi Taniwaki; Mihoko Yoshida; Yosuke Matsumoto; Kazuho Shimura; Junya Kuroda; Hiroto Kaneko
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-02-15       Impact factor: 2.576
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.